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Abstract
Introduction Unloader braces are non-surgical treatment
options for patients with unicompartmental knee
osteoarthritis (OA). However, many patients do not adhere
to brace treatment because of complications related to
discomfort and poor fit. An alternative to knee bracing is an
ankle–foot orthosis (AFO) with a lever arm that presses the
lower leg into valgus or varus. The aim of this study is to
evaluate the clinical benefits of this AFO for patients with
unicompartmental knee OA.
Materials and methods Twenty-three patients with knee
OA were enrolled in this observational study. The primary
clinical outcome measure was the Western Ontario and
McMasters Universities Arthritis Index (WOMAC) total
score. Secondary outcome measures included WOMAC
subscores, visual analogue pain scale, activity restriction
and complication rate. Clinical scores were collected at
start and 3, 6, 9, and 12 months after enrollment. Statistical
evaluation was performed using the Student’s t test.
Results Of the patients enrolled, 83 % suffered from
medial compartment OA. Most patients had Grade II OA
according to the Kellgren and Lawrence classification.
WOMAC total score, both subscores and visual analogue
pain scale were significantly improved over time. Patients
also noted a reduction in restrictions to activities of daily
living and sport-related activities while using the AFO. No
patients discontinued orthosis use because of adverse
effects. Two types of complications were noted: discomfort
or light pressure sores around the ankle (7 patients), and
wear and tear of the shoe in which the AFO was worn (14
patients).
Conclusions This observational study suggests that this
AFO is effective at significantly reducing pain and stiffness
as well as improving the physical function of patients with
mild to moderate unicompartmental osteoarthritis of the
knee.
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Introduction
Osteoarthritis (OA) is the most common joint disease, with
a prevalence of 6 % [7]. OA prevalence increases with
age [1].
In patients with knee OA, the medial joint compartment
is more commonly affected than the lateral compartment
[7]. During normal gait, except for a brief abduction
moment after initial heel contact, the knee joint is subjected
to an external adduction moment throughout the stance
phase [4, 5, 8–12, 16, 19, 20]. This adduction moment is
responsible for the load shift from the lateral to medial
compartment. This load shift even occurs in the presence of
a valgus knee deformity [3–5, 11, 13, 20–22]. The com-
bination of adduction moment and increased medial
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compartment loads are thought to be responsible, in part,
for the high incidence of medial knee OA.
The amplitude of the external adduction moment
applied to the knee depends on the joint’s mechanical
alignment and ground reaction forces. In patients with
medial knee OA, the medial joint space narrows as a result
of cartilage degeneration, which shifts the mechanical
alignment of the knee into varus. This shift can result in an
even greater external adduction moment [22], unless the
patient develops a compensatory gait pattern that involves
toeing out. A reduction in proprioception [2, 19] that
occurs regularly in patients with OA predisposes the joint
to abnormal kinematics. These changes are compounded by
an increased external varus moment that shifts more load
onto the affected compartment, which may also promote
degeneration.
A permanent solution for the correction of lower
extremity malalignment is a high tibial osteotomy [17].
However, surgical treatment is always associated with risks
such as thrombosis, embolism and infection. Conservative
treatment options include the use of lateral wedged insoles
[2, 9, 14, 20] and knee unloader braces
[5–7, 10–12, 16, 22], which can be adjusted to produce a
valgus thrust to unload the medial compartment or a varus
thrust to unload the lateral compartment. A systematic
review of biomechanical studies concluded that knee
unloader braces reduce external moments acting on the
knee joint [16].
Randomized controlled trials have shown that knee
bracing results in improved knee function compared with
no bracing in patients with OA and varus malalignment
[10]. However, a side effect of brace treatment is skin
irritation caused by the condylar pads or straps, which may
lead to treatment non-adherence [22].
A new strategy for correcting varus malalignment is to
apply an external valgus force to the knee with an ankle-
foot orthosis (AFO) (Fig. 1). This AFO (Agilium Free-
step, Otto Bock, Duderstadt, Germany) consists of a non-
flexible insole that is connected to a lever with a pad, which
in turn applies a valgus force to the lower leg [21, 22]. Skin
irritation should be minimized because of the lack of
condylar pads.
Recent biomechanical studies have shown that this new
brace concept is effective at reducing the knee abduction
moment compared with treatment with insoles alone
[6, 21]. However, there are no clinical studies that examine
the effects of this new brace.
Here we assessed if this AFO has beneficial effects on
the symptoms of patients with unicompartmental knee OA.
Our hypothesis was that the use of an AFO improves OA
related symptoms as measured with the Western Ontario
and McMasters Universities Arthritis Index (WOMAC) in
patients with unicompartmental knee OA.
Methods
Study design
This prospective cohort study was conducted at a private
practice, the Orthopaedic Department of the Martin Luther
Hospital, and the Department of Orthopedics and Trauma
Surgery at the University of Go¨ttingen.
A sample size calculation revealed that the inclusion of
22 patients would permit statistically significant
improvements in WOMAC score in this study. Calculat-
ing a potential dropout rate of three patients, 25 patients
were included in this study. Inclusion criteria were: (1)
age over 18; and (2) unicompartmental knee OA (medial
or lateral). Medial OA was defined as pain located in the
medial joint space in combination with radiographic signs
of OA (Grade I or higher). Radiographic signs of OA
were assessed with standing X-rays using the Kellgren
and Lawrence classification (Grades 0–IV). Exclusion
criteria included the following: (1) no knowledge of the
German language; and (2) pain that was not caused by
medial or lateral knee OA. Patients who qualified as study
participants based on these inclusion and exclusion crite-
ria were informed about the study. This discussion
included general information about medial OA and a
description of the study protocol.
All patients included in this study gave their written
informed consent to participate and to have their outcomes
documented using standardized questionnaires. This study
design was approved by the medical ethics committee of
the medical faculty of the Charite´—Universita¨tsmedizin
Berlin (EA 1/069/15, 26.3.2015).
After enrollment, each patient had an ankle–foot
orthosis fitted by a technician. Each patient´s demographic
data (name, sex, and age), baseline medical findings (ra-
diographic assessment of OA, leg alignment and treatment
history) and primary and secondary outcome measures
were collected.
The ankle–foot orthosis (AFO)
The AFO (Agilium Freestep, Otto Bock HealthCare) is a
CE-certified medical device approved in the European
Union for the treatment of medial and lateral unicompart-
mental knee osteoarthritis (OA). The orthosis is available
in four sizes each for the left and right leg, and is indi-
vidually adjusted by a technician. The size was selected
based on the shoe size of the patient. This AFO shifts the
center of pressure (CoP), defined as the application point of
the ground reaction force (GRF) under the foot, 7–10 mm
lateral (Fig. 1) or medial in cases of lateral knee com-
partment OA. It also locks the subtalar joint and keeps the
calf upright to ensure proper force transmission to the knee
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joint. As a result, the lever arm of the GRF, and thus the
external frontal moment acting on the knee, is reduced.
On the contralateral side, an insole was applied to bal-
ance the base plate of the orthosis.
Participants were instructed to wear the orthosis for as
long as possible. The duration of therapy was not limited.
Additional conservative therapies were permitted. A
surgical procedure during the follow-up period on the
ipsilateral lower extremity was criteria for study exclusion.
Outcome measures
Our primary outcome measure was the WOMAC total
score. Our secondary outcome criteria were the WOMAC
subscores, pain measured using a visual analogue scale
(VAS), adverse effects and restrictions to activities of
daily living (ADL) and sport-related activities. ADL and
sport-related activity restriction were assessed using a
four-item Lickert scale (none, little, moderate and severe).
Other secondary outcome measures included the duration
of average daily AFO use (in hours), occurrence of and
reasons for longer-term (C2 week) discontinuation of
orthosis use, use and dosage of non-steroidal anti-in-
flammatory drugs (NSAIDs) and adverse events related to
orthosis use (including discomfort, sore limbs and wear
and tear).
Follow-up visits were scheduled after 3, 6, 9, and
12 months.
Statistics
Most data were evaluated with descriptive statistics.
WOMAC total and subscores, as well as knee pain mea-
sured with VAS underwent comparative statistics with the
Student’s t test for paired samples using WinStat for
Microsoft Excel (Redmond, WA, USA).
Results
General demographic and baseline health data
Twenty-five patients were enrolled in this study. Two
patients dropped out after 2 and 5 months. The first patient
terminated participation because of bunion surgery, and the
second patient moved to a different region of Germany.
The complete datasets of 23 patients were available for
final intention-to-treat analysis, which used a last-obser-
vation-carried-forward method to extrapolate the data
points for the two drop-outs.
Out of the 25 enrolled patients, 15 (60 %) were male
and 10 (40 %) were female, with a mean age of
60.5 ± 11.7 years. Fifteen patients (60 %) had OA of the
left knee and 10 (40 %) had an affected right knee.
The medial compartment was affected by osteoarthritis
in 21 patients (83 %), whereas the lateral compartment was
affected in four patients (17 %). Based on the Kellgren and
Lawrence classification, at baseline eight patients (33 %)
had Grade I osteoarthritis, 14 (55 %) had Grade II
osteoarthritis and three (12 %) had Grade III osteoarthritis.
Ten patients (40 %) demonstrated a neutral leg axis, 11
(44 %) had a varus deviation and four (12 %) had a valgus
deviation.
Primary outcome measure
As presented in Fig. 2, the WOMAC total score was sig-
nificantly improved following AFO use at all follow-up
Fig. 1 Mechanisms and effects
of a novel ankle–foot orthosis
(Agilium Freestep, Otto Bock,
Duderstadt, Germany) in the
management of medial knee
osteoarthritis
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visits compared with baseline scores (40.9 ± 13.4). After
3 months the intervention group had a WOMAC of
25.1 ± 22.3 (p\ .03), followed by 20.8 ± 17.3
(p\ .0001) at the 6-month follow-up. It continued to trend
down at the 9- (20.2 ± 20.1, p\ .0001) and 12-month
follow-ups (16.6 ± 23.3, p\ .001).
WOMAC subscores
The WOMAC pain subscore was significantly improved
during AFO use (Fig. 3). A baseline of 9.1 ± 2.8 improved
to 3.7 ± 5.1 (p\ .004) at the 12-month follow-up.
The WOMAC stiffness subscore is shown in Fig. 4. This
subscore also improved significantly from baseline
(4.3 ± 2.0) to the 6-month (2.2 ± 1.8; p\ .0004),
9-month (2.3 ± 1.9; p\ .0003), and 12-month (1.9 ± 2.0;
p\ .0003) follow-ups.
Figure 5 demonstrates the WOMAC physical function
subscore. This score significantly decreased from baseline
(27.4 ± 10.5) to the 6-month follow-up (13.9 ± 13.3,
p\ .0003), the 9-month follow up (13.2 ± 14.2,
p\ .0002) and the 12-month follow-up (11.0 ± 16.3,
p\ .0002).
Knee pain (VAS)
Quantitative VAS pain assessment (Fig. 6) was signifi-
cantly improved at the 6-month (3.7 ± 2.3, p\ .03) and
12-month follow-ups (3.4 ± 2.8, p\ .04) compared with
baseline (4.9 ± 1.6).
NSAID use
Fourteen patients used NSAIDs prior to the start of the
study, 10 of whom reported a dosage reduction of 50 % or
more when using the orthosis.
ADL and sport-related activity restrictions
Perceived restrictions to activities of daily living and sport-
related activities decreased over time during AFO use
(Figs. 7, 8).
Orthosis use
Seventeen patients wore the AFO for 4–8 h daily. One
patient wore it less than 4 h a day and five patients
extended their usage to more than 8 h daily.
Fig. 2 Change in WOMAC total score from baseline to 12-month
follow-up with AFO use (* = statistically significant difference
compared with baseline)
Fig. 3 Change in WOMAC pain subscore from baseline to 12-month
follow-up with AFO use (* = statistically significant difference
compared with baseline)
Fig. 4 Change in WOMAC stiffness subscore from baseline to
12-month follow-up with AFO use (* = statistically significant
difference compared with baseline)
Fig. 5 Change in WOMAC physical function subscore from baseline
to 12-month follow-up with AFO use (* = statistically significant
difference compared with baseline)
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No patients discontinued their use of the orthosis com-
pletely. Seven of the 23 patients reported non-use of the
orthosis for 14 days during the 12-month follow-up period.
Two patients had to interrupt their orthosis use during
hospital stays unrelated to their knee OA. Four patients did
not use their orthosis during a vacation, and one patient had
to interrupt AFO use because of a technical defect that
required a repair.
Adverse events
During the 12-month follow-up period, two types of
adverse events were observed. Discomfort or light pressure
sores around the ankle were seen in seven patients. These
adverse effects were observed within the first 4 weeks after
initial orthosis fitting. All complaints were well managed
with additional adjustments or orthosis padding by a
technician. Wear and tear of the shoe on the AFO side was
seen in 14 patients after longer AFO use, usually at the 9-
and 12-month follow-up visits.
Discussion
This is the first clinical outcome study of the use of a new
AFO for unicompartmental knee OA. The results of this
study confirmed our hypothesis. The AFO improved
WOMAC total score as well as its three subscores: pain,
stiffness and physical function.
Improvements in WOMAC total and subscores were
about 50 % after 6 and 12 months, which was roughly the
efficacy of studies that evaluated knee unloader braces
[3, 5, 7].
The improvement in pain VAS score of about 30 % after
AFO use, which was statistically significant at the 6- and
12-month follow-ups, was also comparable to that observed
in clinical trials of knee unloader braces [6, 10, 12, 18].
These clinical effects confirm previous biomechanical
studies that have shown that an AFO has the potential to
reduce the knee adduction moment in patients with medial
OA [6, 20]. Fantini et al. [6] found significant decreases in
knee adduction moment, knee lever arm and joint align-
ment in the frontal plane with an AFO. Schmalz et al. [20]
found that an AFO that is rigid in the frontal plane sig-
nificantly reduced the maximal adduction moment of the
knee from 0.54 Nm/kg to 0.38 Nm/kg.
The clinical and biomechanical effects of clinical inter-
ventions such as unloader braces, which are recommended
by the Osteoarthritis Research Society International guide-
lines for the treatment of knee OA, are well documented
[3, 9]. A downside of unloader brace treatment is the high
rate of therapy discontinuation. In one prospective random-
ized trial, the compliance with brace treatment was only
45 % [23]. Causes for the discontinuation of brace treatment
include a lack of therapeutic benefit or adverse effects such as
abrasions, bruises, sores and blisters at the level of the
condylar knee pads [23]. In our study, seven of 23 patients
reported a partial discontinuation of AFO use for 14 days or
longer during the course of their study participation. In six of
Fig. 6 Change in VAS pain score from baseline to 12-month follow-
up with AFO use (* = statistically significant difference compared
with baseline)
Fig. 7 ADL restriction over time with AFO use as measured with a
four-point Lickert scale
Fig. 8 Sport and leisure activity over time with AFO use as measured
with a four-point Lickert scale
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these patients the cause for discontinuationwas not related to
the orthosis (vacation or unrelated hospital stay). However,
discomfort or light pressure sores around the ankle were
evident in seven patientswithin the first 4 weeks ofAFOuse.
These problems were managed with additional adjustments
to the orthosis by a technician. The second type of adverse
events, wear and tear of the shoe inwhich theAFOwasworn,
was seen in 14 patients after longer AFO use, typically at the
9- and 12-month follow-up visits.
The optimal daily brace use time has not yet been
determined [23]. Van Raaij et al. [23] defined compliance
as brace use of 6 h a day. In our study the majority of
patients (17/23) wore their orthosis for 4–8 h per day [23].
Our results, in combination with previous biomechanical
findings [6], suggest that this new AFO design is a sound
alternative to conventional knee unloader braces. However,
this study has two important limitations. First, this study is
not a prospective randomized trial. We lacked a control or
placebo group. Prospective randomized trials are needed to
further confirm the benefits of this AFO. However, our
study design allowed us to avoid several disadvantages of
randomized controlled trials. Lack of generalizability is a
major problem for randomized clinical trials (RCTs) [15].
Normally, only a small percentage of the patients can
typically be enrolled in an RCT because of strict enroll-
ment criteria [15, 18]. The participation rate of some RCTs
is less than 15 % [15]. RCT enrollment can therefore be far
from the ‘‘real world’’, making findings difficult to translate
into the general population. In our study the eligibility
criteria were not highly selective, and patients who were
recruited were representative of the patients in our local
community. The second limitation of our study is that the
examiner was also the caregiver, and the one who informed
the patient about the aims of the study. Our study would
have been stronger if the assessor was blinded during
outcome measurement.
In conclusion, the results of our study suggest that the
AFO evaluated here is effective at significantly reducing
the pain and stiffness and improving the physical function
of patients with mild to moderate unicompartmental
osteoarthritis of the knee. The clinical benefits of this AFO
appear to be similar to those demonstrated in clinical trials
of knee unloader braces, although our study suggests that
overall patient compliance with AFOs may be superior to
unloader braces. However, additional prospective ran-
domized studies are needed to further characterize this
AFO in the treatment of unicompartmental OA.
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